Introducing Simoa® Advantage PLUS, the latest advancement for Quanterix RUO assay kits. Simoa® Advantage PLUS assays were carefully designed to improve longitudinal data precision and better support for large-scale research studies. Developed by integrating invaluable customer insights and cutting-edge technology, Simoa® Advantage PLUS assay technology brings new lot-to-lot consistency and sustainability to previous chemistry innovations as a testament to an unwavering dedication to delivering the gold standard in industry-leading ultra-sensitive assays.
From discovery to diagnostics, our Simoa® Advantage PLUS assays can fuel your research through the ability to identify and examine critical biomarkers less invasively, more efficiently, and with higher accuracy when compared to other analog methods.
With the introduction of Simoa® Advantage PLUS, Quanterix sets a new benchmark for RUO assay kits. Emphasizing lot-to-lot consistency, increased lot sizes, and sustainability, we showcase our unwavering dedication to ensuring industry-leading assay performance and stability.
Complete the form for more info and to download our one-page information sheet.
Simoa® Advantage PLUS combines the power of Quanterix’s instrument technology and Simoa® ultra-sensitive digital immunoassays to elevate the precision, consistency, efficiency, and sustainability of your biomarker research. Don't miss the opportunity to revolutionize your data collection and analysis with this cutting-edge solution.
Complete the form to download our one-pager and request more information from your sales rep about Advantage Plus.
Developed by integrating invaluable customer insights and cutting-edge advancements, Advantage PLUS stands as a testament to Quanterix’s unwavering dedication to delivering the gold standard in industry-leading ultra-sensitive assays.
Unleash the potential of groundbreaking discoveries in neurology, oncology, infectious diseases, and more with Simoa® bead technology with our flagship HD-X automated immunoassay analyzer, offering ultrasensitive multiplex biomarker detection.